| Product Name | MF | CAS | Details |
|---|
| Thalidomide-NH-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2460022-53-9 | Details |
| NS2B/NS3-IN-3 hydrochloride | C19H21N3O2.ClH | 2832876-91-0 | Details |
| Smurf1-IN-1 | C24H29ClN6O2 | 1824708-03-3 | Details |
| Yhhu6669 | 2569526-80-1 | Details |
| BRD4 Inhibitor-28 | 2468960-80-5 | Details |
| NLRP3-IN-21 | 2956791-61-8 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| TRK-IN-23 | 2924344-29-4 | Details |
| HPK1-IN-35 | 2935903-77-6 | Details |
| AMX12006 | 2639775-01-0 | Details |
| BChE/HDAC6-IN-1 | 2925457-27-6 | Details |
| AJH-836 | 388621-67-8 | Details |
| HIV-1 protease-IN-8 | 2925287-55-2 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| NLRP3-IN-17 | C21H22N4O2S | 2254432-75-0 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| EGFR-IN-82 | 2568086-81-5 | Details |
| SIRT5 inhibitor 7 | 2951090-00-7 | Details |
| Quorum Sensing-IN-2 | 2925926-80-1 | Details |
| Antileishmanial agent-16 | 2934738-41-5 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| CYP11A1-IN-1 | C27H34N2O5 | 2744168-51-0 | Details |
| SHP2-IN-13 | 2951854-02-5 | Details |
| SIRT5 inhibitor 6 | 2834736-82-0 | Details |
| EP12 | 2882916-73-4 | Details |
| ATR-IN-23 | 2923800-62-6 | Details |
| HIV-1 inhibitor-57 | 2745197-24-2 | Details |
| SJ1461 | 2924546-70-1 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| J-1048 | 2374772-60-6 | Details |
| YIAD-0205 | 2446054-34-6 | Details |
| HIF-2α-IN-9 | 2648334-36-3 | Details |
| Antileishmanial agent-17 | 2934738-40-4 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| SDH-IN-5 | C16H19F2N3O2 | 2922765-95-3 | Details |
| LTB4 antagonist 2 | 2929239-85-8 | Details |
| SARS-CoV-2 nsp14-IN-3 | C17H17N3O3S | 2920574-16-7 | Details |
| DNA gyrase B-IN-3 | 2412834-56-9 | Details |
| TWIK-1/TREK-1-IN-1 | 1440532-30-8 | Details |
| CDK/HDAC-IN-3 | 2944087-54-9 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | C23H32N4O4.ClH | 2863635-00-9 | Details |
| Lepzacitinib | C18H21N5O3 | 2321488-47-3 | Details |
| Anticancer agent 164 | 2235393-30-1 | Details |
| Dim16 | 2743448-32-8 | Details |
| Aurora Kinases-IN-4 | 2877011-84-0 | Details |
| BC-05 | 2260717-73-3 | Details |
| LSD1-UM-109 | 2252446-26-5 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| JNJ-1013 | C46H55N9O7S | 2597343-08-1 | Details |
| S07-1066 | C16H11Cl2FO2 | 876625-29-5 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| MY-673 | 2944459-96-3 | Details |
| HDAC-IN-63 | 2920046-95-1 | Details |
| NNRTIs-IN-1 | 2925364-09-4 | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| Tubulin inhibitor 33 | 2944462-67-1 | Details |
| LTB4 antagonist 3 | 2929239-87-0 | Details |
| hnNOS-IN-2 | 2700326-00-5 | Details |
| MmpL3-IN-3 | 1639438-67-7 | Details |
| Chitin synthase inhibitor 14 | 2922114-19-8 | Details |
| S-F24 | 2946669-78-7 | Details |
| Antileishmanial agent-15 | 2934738-38-0 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| HDAC-IN-58 | C16H13ClF2N4O3S | 2071224-39-8 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| Antitubercular agent-37 | C22H22N8O2 | 21696-12-8 | Details |
| SIKs-IN-1 | 2927557-06-8 | Details |
| ZINC475239213 | 2871002-89-8 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| BODIPY FL thalidomide | C37H43BF2N6O7 | 2740620-18-0 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||